SCP Vitalife Partners — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Avedro, Inc.avedro.com in 𝕏Nov 2014acquired by Glaukos

Avedro is an ophthalmic company focused on corneal health, known for bio-activated cross-linking therapies such as the KXL system and riboflavin-based treatments used to address progressive keratoconus.

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)in Brian J. Roberts(Executive Officer)in Rhonda J. Bracey(Executive Officer)inThomas W. Burns(Chairman & Chief Executive Officer)

BoardJason Hong(Director)

Board seat Jeff Dykan· per SEC Form D

Co-investorsAPERTURE Venture Partners LAV Lilly Asia Ventures Third Point Ventures Western Technology Investment Abingworth +5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.